TP53 and ovarian carcinoma: Given that BAG2 was reported to interact with mutant p53 and mutant p53 aggregates were found to promote chemoresistance in ovarian cancer 29, we hypothesized that BAG2 might regulate the generation of mutant p53 aggregates to induce chemoresistance.